
NAII
Natural Alternatives International Inc
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
3.660
Open
3.590
VWAP
3.62
Vol
1.68K
Mkt Cap
22.37M
Low
3.580
Amount
6.09K
EV/EBITDA(TTM)
--
Total Shares
6.20M
EV
22.76M
EV/OCF(TTM)
--
P/S(TTM)
0.17
Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. Its primary business activity is to provide private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbs, and other nutritional supplements, as well as other health care products, to consumers both within and outside the United States. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer ecommerce channels, and retail stores. It manufactures products in a variety of forms, including capsules, tablets, chewable wafers, and powders to accommodate a variety of its customer’s preferences. It also seeks to commercialize its patent and trademarks through the direct distribution and sale of CarnoSyn, SR CarnoSyn, TriBsyn, new contract manufacturing opportunities, and various license, royalty, and similar arrangements.
Show More
Valuation Metrics
The current forward P/E ratio for Natural Alternatives International Inc (NAII.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Natural Alternatives International Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
Financials
Annual
Quarterly
FY2025Q3
YoY :
+14.44%
28.77M
Total Revenue
FY2025Q3
YoY :
+7.58%
-2.10M
Operating Profit
FY2025Q3
YoY :
+38.53%
-2.19M
Net Income after Tax
FY2025Q3
YoY :
+37.04%
-0.37
EPS - Diluted
FY2025Q3
YoY :
-233.10%
5.19M
Free Cash Flow
FY2025Q3
YoY :
-16.99%
6.35
Gross Profit Margin - %
FY2025Q3
YoY :
-149.44%
-2.65
FCF Margin - %
FY2025Q3
YoY :
+21.02%
-7.60
Net Margin - %
FY2025Q3
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
NAII News & Events
Events Timeline
2024-10-24 (ET)
2024-10-24
17:52:28
CarnoSyn Brands announces new U.S. distribution pact with B&D Nutritional

Sign Up For More Events
Sign Up For More Events
News
7.5
07-21NewsfilterNatural Alternatives International, Inc. Announces New Manufacturing Agreement with The Juice Plus+® Company
9.5
05-14NewsfilterNatural Alternatives International, Inc. Announces 2025 Q3 and YTD Results
9.0
03-05NewsfilterNatural Alternatives International and CarnoSyn® Brands Publish Clinical Research Demonstrating TriBsyn™ Delivering Exceptional Bioavailability, Increased Efficiency and Paresthesia Elimination
Sign Up For More News
People Also Watch

NRSN
Neurosense Therapeutics Ltd
2.030
USD
0.00%

CVV
CVD Equipment Corp
3.740
USD
-5.08%

CODX
Co-Diagnostics Inc
0.280
USD
-1.41%

FEMY
Femasys Inc
0.900
USD
-1.64%

NISN
Nisun International Enterprise Development Group Co Ltd
4.370
USD
-4.17%

LGVN
Longeveron Inc
1.670
USD
-1.18%

ORKT
Orangekloud Technology Inc
0.795
USD
+11.34%

CNTM
ConnectM Technology Solutions Inc
0
USD
-48.40%

CHR
Cheer Holding Inc
1.890
USD
-5.03%

SAG
SAG Holdings Ltd
0
USD
-2.97%
FAQ

What is Natural Alternatives International Inc (NAII) stock price today?
The current price of NAII is 3.6199 USD — it has decreased -0.82 % in the last trading day.

What is Natural Alternatives International Inc (NAII)'s business?

What is the price predicton of NAII Stock?

What is Natural Alternatives International Inc (NAII)'s revenue for the last quarter?

What is Natural Alternatives International Inc (NAII)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Natural Alternatives International Inc (NAII)'s fundamentals?

How many employees does Natural Alternatives International Inc (NAII). have?
